Improving Clinical Trial Enrollment — In the Covid-19 Era and Beyond von North, Crystal M, Dougan, Michael L, Sacks, Chana A

Volltext

Impact of systemic corticosteroids on survival outcomes in immune checkpoint inhibitor–induced gastroenterocolitis von Thompson, Leah L., Katznelson, Ethan, Leet, Donna E., Durbin, Sienna M., Yoon, Jaewon, Reynolds, Kerry L., Dougan, Michael L., Chen, Steven T.

Volltext

CoVA: An Acuity Score for Outpatient Screening that Predicts Coronavirus Disease 2019 Prognosis von Sun, Haoqi, Jain, Aayushee, Leone, Michael J, Alabsi, Haitham S, Brenner, Laura N, Ye, Elissa, Ge, Wendong, Shao, Yu-Ping, Boutros, Christine L, Wang, Ruopeng, Tesh, Ryan A, Magdamo, Colin, Collens, Sarah I, Ganglberger, Wolfgang, Bassett, Ingrid V, Meigs, James B, Kalpathy-Cramer, Jayashree, Li, Matthew D, Chu, Jacqueline T, Dougan, Michael L, Stratton, Lawrence W, Rosand, Jonathan, Fischl, Bruce, Das, Sudeshna, Mukerji, Shibani S, Robbins, Gregory K, Westover, M Brandon

Volltext

Evaluation of appendectomy as a potential risk factor for immune checkpoint inhibitor-associated enterocolitis von Krasnow, Nira A, Chute, Donald F, Falade, Ayo S, North, Crystal M, Reynolds, Kerry L, Dougan, Michael L

Volltext

Molecular Tracer Dynamics in Crystalline Organic Films at the Solid−Liquid Interface von Padowitz, David F, Sada, David M, Kemer, Eric L, Dougan, Michael L, Xue, W. Andrew

Volltext

Impact of immune checkpoint inhibition on ovarian reserve in patients with melanoma enrolled in the ECOG-ACRIN E1609 adjuvant trial von Buchbinder, Elizabeth Iannotti, Song, Zihe, Lee, Sandra J., Keefe, Kimberly W., Manos, Michael P., Tarhini, Ahmad A., Dougan, Michael L., Cohen, Justine Vanessa

Volltext

Prognostic implications of co-occurring dermatologic and gastrointestinal toxicity from immune checkpoint inhibition therapy for advanced malignancies: A retrospective cohort study von Molina, Gabriel E., Allen, Ian M., Hughes, Michael S., Zubiri, Leyre, Lee, Hang, Mooradian, Meghan J., Reynolds, Kerry L., Dougan, Michael, Chen, Steven T.

Volltext

Who will manage American patients with diabetes? Residents' career preferences and perceptions of diabetes care von Yarchoan, Mark, Dougan, Michael L, Tjota, Melissa Y, Milliner, Brendan H A, Adler, Brittany L, Armah, Kaku A, Gooley, Ted A, Close, Kelly L, Close, John, Hirsch, Irl B

Volltext

Impact of systemic corticosteroids on survival outcomes in immune checkpoint inhibitoreinduced gastroenterocolitis von Thompson, Leah L., Katznelson, Ethan, Leet, Donna E., Durbin, Sienna M., Yoon, Jaewon, Reynolds, Kerry L., Dougan, Michael L., Chen, Steven T.

Volltext

Impact of systemic corticosteroids on survival outcomes in patients with immune-checkpoint inhibitor enterocolitis von Thompson, Leah L., Katznelson, Ethan, Leet, Donna E., Durbin, Sienna, Yoon, Jaewon, Park, Jin K., Dougan, Michael L., Chen, Steven T.

Volltext

Outcomes of immune checkpoint inhibitor-mediated colitis: Multicenter cohort study von Abu-Sbeih, Hamzah, Tang, Tenglong, Faleck, David M., Dougan, Michael L., Olsson-Brown, Anna, Johnson, Douglas Buckner, Owen, Dwight Hall, Warner, David Engar, Philipp, Alexander B, Powell, Nick, Daniels, Ella, Philpott, Jessica, Weppler, Alison Margaret, Pinato, David James, Wang, Yinghong

Volltext

Rapid cleavage of cyclic tertiary amides of Kemp's triacid: effects of ring structure von Dougan, Michael L, Chin, Jonathan L, Solt, Ken, Hansen, David E

Volltext

A phase 1b study of nivolumab in patients with autoimmune disorders and advanced malignancies (AIM-NIVO) von Dumbrava, Ecaterina Elena, Dougan, Michael L., Gupta, Sarthak, Cappelli, Laura, Katsumoto, Tamiko R., Rahma, Osama E., Painter, Jeane, Wang, Yinghong, Suarez-Almazor, Maria E., Reid, Pankti, Wesley, Sarah F., Hafler, David A, Bingham, Clifton O., Warner, Blake M, Chung, Lorinda, Ott, Patrick Alexander, Kluger, Harriet M., Khosroshahi, Arezou, Tawbi, Hussein Abdul-Hassan, Sharon, Elad

Volltext

Abstract CT249: A phase 1b study of nivolumab in patients with autoimmune disorders and advanced malignancies (AIM-NIVO) von Ileana Dumbrava, Ecaterina E., Suarez-Almazor, Maria, Painter, Jeane, Johanns, Tanner M., Dougan, Michael L., Cappelli, Laura, Wang, Yinghong, Bingham, Clifton, Gupta, Sarthak, Warner, Blake M., Rahma, Osama, Naidoo, Jarushka, Ott, Patrick A., Hafler, David A., Kluger, Harriet, Khosroshahi, Arezou, Naqash, Rafeh, Chung, Lorinda, Katsumoto, Tamiko R., Kummar, Shivaani, Tawbi, Hussein, Sharon, Elad

Volltext

A phase Ib study of nivolumab in patients with autoimmune disorders and advanced malignancies (AIM-NIVO) von Ileana Dumbrava, Ecaterina Elena, Suarez-Almazor, Maria E., Painter, Jeane, Johanns, Tanner, Dougan, Michael L., Cappelli, Laura, Bingham, Clifton O., Wang, Yinghong, Gupta, Sarthak, Warner, Blake M, Rahma, Osama E., Naidoo, Jarushka, Ott, Patrick Alexander, Hafler, David A, Kluger, Harriet M., Khosroshahi, Arezou, Katsumoto, Tamiko R, Kummar, Shivaani, Sharon, Elad, Tawbi, Hussein Abdul-Hassan

Volltext

Severe metabolic alkalosis after bladder reconstruction von NAKAGAWA, THOMAS A, GOMEZ, ROBERT J, DOUGAN, MICHAEL L

Volltext

Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy von Luoma, Adrienne M., Suo, Shengbao, Williams, Hannah L., Sharova, Tatyana, Sullivan, Keri, Manos, Michael, Bowling, Peter, Hodi, F. Stephen, Rahma, Osama, Sullivan, Ryan J., Boland, Genevieve M., Nowak, Jonathan A., Dougan, Stephanie K., Dougan, Michael, Yuan, Guo-Cheng, Wucherpfennig, Kai W.

Volltext

Anti–CTLA-4 therapy requires an Fc domain for efficacy von Ingram, Jessica R., Blomberg, Olga S., Rashidian, Mohammad, Ali, Lestat, Garforth, Scott, Fedorov, Elena, Fedorov, Alexander A., Bonanno, Jeffrey B., Le Gall, Camille, Crowley, Stephanie, Espinosa, Camilo, Biary, Tamara, Keliher, Edmund J., Weissleder, Ralph, Almo, Steven C., Dougan, Stephanie K., Ploegh, Hidde L., Dougan, Michael

Volltext

Localized CD47 blockade enhances immunotherapy for murine melanoma von Ingram, Jessica R., Blomberg, Olga S., Sockolosky, Jonathan T., Ali, Lestat, Schmidt, Florian I., Pishesha, Novalia, Espinosa, Camilo, Dougan, Stephanie K., Garcia, K. Christopher, Ploegh, Hidde L., Dougan, Michael

Volltext

PD-L1 is an activation-independent marker of brown adipocytes von Ingram, Jessica R., Dougan, Michael, Rashidian, Mohammad, Knoll, Marko, Keliher, Edmund J., Garrett, Sarah, Garforth, Scott, Blomberg, Olga S., Espinosa, Camilo, Bhan, Atul, Almo, Steven C., Weissleder, Ralph, Lodish, Harvey, Dougan, Stephanie K., Ploegh, Hidde L.

Volltext